There are multiple other semaglutide brands in the market, and now ... compounded versions of popular drugs like Ozempic, Mounjaro, Wegovy, and Zepbound, warning patients about the dangers of ...

Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

in an echo of Friday’s sell-off amid concerns about the fate of its Ozempic alternatives. Shares of Hims & Hers HIMS — which sells drugs like Cialis and anti-anxiety medications — tumbled 18 ...

NVO, CRBP and SKYE are tapping into the booming obesity market with novel CBD-based therapies, offering alternatives amid ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

NVO stock declines 3% as the company announces that Lars Fruergaard Jorgensen will be stepping down as the CEO.

In this week's newsletter, also read about why Indian pharma companies are fast-tracking alternatives to weight-loss ...

A look inside the rise of "The Barbie Drug," an unregulated, understudied injection that promises bronzed skin—and a load of ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...